PATENT CLAIM ANALYSIS

Application Number: 16003990
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["546", "081000"]

Abstract:
The present invention relates to compounds of formulas III and V that are useful as pharmaceutical agents, particularly as autophagy inhibitors.

Claim (Index 20):
The method of  claim 19 , where in the condition or disease is cancer, a neurodegenerative disorder, an autoimmune disorder, a cardiovascular disorder, a metabolic disorder, hamartoma syndrome, a genetic muscle disorder, or a myopathy.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 94.0
- Lexical Diversity: 1.04545
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14116650', '15384823', '13995889', '14173072', '12316848']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7407046949420124
- 35 USC 102 Novelty (BERT): 0.5379976959483544
- Combined Prediction Score: 0.7204339950426466
- Mean Citation Score: 256.67405799999995
- Max Citation Score: 352.04474
- Similarity Product: 187.1700650986623

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test